Evidence map›Paper›PMID 42339379›Full record

ArticleJournal of the Endocrine Society2026

Prevalence of diabetes mellitus in long-term cancer survivors treated with craniospinal irradiation.

Franziska Richter, Cassandra Runow, Denise Obrecht-Sturm, Lea L Kronziel, Stefan Rutkowski, Desiree Grabow, Christian Denzer, Thorsten Langer, Judith Gebauer

Abstract read
In one paragraph

Article in Journal of the Endocrine Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Franziska RichterDepartment of Pediatric Oncology and Hematology, University Medical Center Schleswig-Holstein, 23562 Luebeck, Germany.ORCID https://orcid.org/0009-0001-6921-7385
Cassandra RunowDepartment of Pediatric Oncology and Hematology, University Medical Center Schleswig-Holstein, 23562 Luebeck, Germany.
Denise Obrecht-SturmDepartment of Pediatric Oncology and Hematology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.ORCID https://orcid.org/0000-0002-3216-8452
Lea L KronzielInstitute of Medical Biometry and Statistics, University of Luebeck, 23562 Luebeck, Germany.
Stefan RutkowskiDepartment of Pediatric Oncology and Hematology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.ORCID https://orcid.org/0000-0002-5446-9571
Desiree GrabowDivision of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.ORCID https://orcid.org/0000-0002-4853-3303
Christian DenzerDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University Medical Center, 89075 Ulm, Germany.
Thorsten LangerDepartment of Pediatric Oncology and Hematology, University Medical Center Schleswig-Holstein, 23562 Luebeck, Germany.ORCID https://orcid.org/0000-0002-7047-2957
Judith GebauerDepartment of Hematology and Oncology, University Medical Center Schleswig-Holstein, 23562 Luebeck, Germany.ORCID https://orcid.org/0000-0003-4428-8010

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Childhood, adolescent, and young adult cancer survivors (CAYA) are at an increased risk for metabolic disorders such as diabetes mellitus. Although this risk has been well-documented for leukemia survivors and those exposed to abdominal radiotherapy, the metabolic risk profile for brain tumor survivors remains largely unexplored. Methods: This study assessed the prevalence of diabetes and dysglycemia in 2 CAYA survivor cohorts. The first included medulloblastoma and ependymoma survivors (HIT-MED), with data collected via self-reported online questionnaires. The second (CLI) was a retrospective analysis of an unselected cohort from our late effects clinic. In this cohort, dysglycemia was defined using hemoglobin A1c measurements alone, without additional glucose-based diagnostic criteria. Results: In the HIT-MED group, 37% (197/527) participated in an online-based questionnaire, revealing a diabetes mellitus prevalence of 3.05%. A total of 122 were male and 75 female, mean age was 27.1 ± 4.5 years (range 19-41). In comparison to an age-matched general population, there was no significant difference ( Conclusion: CAYA brain tumor survivors exposed to craniospinal radiotherapy have an elevated risk of dysglycemia compared to other survivor cohorts. These findings support the need for structured, risk-adapted long-term metabolic monitoring to enable early intervention and reduce long-term morbidity.

Indexed as

childhood cancer survivorsdiabetes mellitusirradiationlate effectsmedulloblastoma

Identifiers

PMID42339379
PMCPMC13284419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.